Compare BRKR & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRKR | PLXS |
|---|---|---|
| Founded | 1960 | 1979 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electrical Products |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.2B |
| IPO Year | 2000 | 1995 |
| Metric | BRKR | PLXS |
|---|---|---|
| Price | $64.22 | $263.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | $48.54 | ★ $206.50 |
| AVG Volume (30 Days) | ★ 2.1M | 173.6K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 4.90 |
| Revenue | ★ $1,895,600,000.00 | N/A |
| Revenue This Year | $6.30 | $14.31 |
| Revenue Next Year | $3.81 | $8.29 |
| P/E Ratio | ★ N/A | $53.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.09 | $132.03 |
| 52 Week High | $65.30 | $307.06 |
| Indicator | BRKR | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 61.46 | 61.19 |
| Support Level | $53.79 | $234.17 |
| Resistance Level | N/A | $297.13 |
| Average True Range (ATR) | 2.98 | 6.31 |
| MACD | 0.77 | 2.97 |
| Stochastic Oscillator | 92.71 | 84.49 |
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.